The EORTC 10041/BIG 03-04 MINDACT trial is feasible: results of the pilot phase.

MLA

Rutgers, Emiel, et al. “The EORTC 10041/BIG 03-04 MINDACT Trial Is Feasible: Results of the Pilot Phase.” European Journal of Cancer, 47 (18, 2011. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.ocn812601623&authtype=sso&custid=ns315887.

APA

Rutgers, E., Piccart-Gebhart, M., Bogaerts, J., Delaloge, S., Van’t Veer, L., Rubio, I. T., Viale, G., Thompson, A., Passalacqua, R., Nitz, U., Vindevoghel, A., Pierga, J.-Y., Ravdin, P., Werutsky, G., & Cardoso, F. (2011). The EORTC 10041/BIG 03-04 MINDACT trial is feasible: results of the pilot phase. European Journal of Cancer, 47 (18.

Chicago

Rutgers, Emiel, Martine Piccart-Gebhart, Jan Bogaerts, Suzette Delaloge, Laura Van’t Veer, Isabel Teresa Rubio, Giuseppe Viale, et al. 2011. “The EORTC 10041/BIG 03-04 MINDACT Trial Is Feasible: Results of the Pilot Phase.” European Journal of Cancer, 47 (18. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.ocn812601623&authtype=sso&custid=ns315887.